Sphinx Trading’s Acceleron Pharma XLRN Stock Holding History

Sphinx Trading’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-700	Closed	-$120K	–	174
2021 Q3	$120K	Buy	+700	New	+$91.6K	0.13%	84

Sphinx Trading's XLRN Position: Q4 2021 in Review

Sphinx Trading sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 700 shares — an estimated $120K sold.

Sphinx Trading first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $120K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Sphinx Trading reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Sphinx Trading sold 700 Acceleron Pharma shares in Q4 2021, an estimated $120K.
Sphinx Trading first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
Sphinx Trading's Acceleron Pharma position peaked at $120K in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Sphinx Trading's 13F filing for Q4 2021, filed 31 Jan 2022.